Drugmaker Investments Will Boost Singapore’s Pharmaceutical Sector, Reflecting Robust Investor Confidence
Pharmaceuticals / Singapore / Thu 23 May, 2024
Key View:
- Ongoing drugmaker investment will boost Singapore’s status as a key pharmaceutical hub.
- The government of Singapore will continue to take a proactive role in developing the market’s biomedical manufacturing industry.
- Through AstraZeneca’s investment, Singapore's position as an important trading hub for the pharmaceutical sector in the